Tag Archives: Stryker

Healthcare Sector Slightly Hikes; Stryker (SYK) Fiscal Q4 Profit Plunges 33% while Abbott (ABT) Guidance Matches Analysts Forecasts – SYK, ABT, PFE, THLD, KERX, CYBX

Posted on January 24, 2013 by Geoff Noir

Healthcare sector responded positively on last trading session and sector moved up +0.07%. If we look at the key healthcare movers so Threshold Pharmaceuticals, Inc (NASDAQ:THLD) and Keryx Biopharmaceuticals (NASDAQ:KERX) were major percentage gainer while major percentage decliner was Cyberonics, …

Posted in Healthcare, Latest Headlines | Tagged Abbott Laboratories, ABT, Cyberonics, CYBX, KERX, Keryx, NASDAQ:CYBX, NASDAQ:KERX, NASDAQ:THLD, NYSE:ABT, NYSE:PFE, NYSE:SYK, PFE, Pfizer, Stryker, SYK, THLD, Threshold Pharmaceuticals | Comments Off

Johnson & Johnson (NYSE:JNJ) Unlike by Berkshire, Eliminates Stake

Posted on November 19, 2012 by Thomas Vedder

Berkshire kept its portfolio same but removed its stake in Johnson & Johnson (NYSE:JNJ) and General Electric (NYSE:GE), as per reported by its 13-F filing with the Securities and Exchange Commission.

The company possessed just above 492,000 shares of J&J …

Posted in Healthcare, Main Post | Tagged JNJ, Johnson, NYSE:JNJ, NYSE:PFE, NYSE:SNY, NYSE:SYK, PFE, Pfizer, Sanofi SA, SNY, Stryker, SYK | Comments Off

Johnson & Johnson (NYSE:JNJ) Outshines Wall Street Forecasts in Third Quarter on New Drug Sales – JNJ, ENDP, GSK, SYK

Posted on October 17, 2012 by Thomas Vedder

The New Brunswick, New Jersey-based Johnson & Johnson (NYSE:JNJ) surpass analysts’ earnings forecasts in the Q3 on demand for new prescription medicines and medical tools purchased with the Synthes Inc acquisition. The world’s biggest manufacturer of health-care products boosted its …

Posted in Healthcare, Latest Headlines | Tagged Endo Health, ENDP, GlaxoSmithKline, GSK, JNJ, Johnson, NASDAQ:ENDP, NYSE:GSK, NYSE:JNJ, NYSE:SYK, Stryker, SYK | Comments Off

BioMimetic Therapeutics (NASDAQ:BMTI) Provides More Data to FDA – BMTI, ZMH, SYK, JNJ

Posted on July 10, 2012 by Geoff Noir

The Franklin, Tennessee-based BioMimetic Therapeutics, Inc (NASDAQ:BMTI) reported on Monday that it submitted more data sought by health regulators for the marketing support of the corporation’s bone graft product, sending its shares high 14% after the bell.

The biotechnology corporation …

Posted in Healthcare, Latest Headlines | Tagged BioMimetic, BMTI, JNJ, Johnson, NASDAQ:BMTI, NYSE:JNJ, NYSE:SYK, NYSE:ZMH, Stryker, SYK, Zimmer, ZMH | Comments Off

Given Imaging (NASDAQ:GIVN)’s Studies Verify, PillCam ESO as A Tool Help Triage Patients- GIVN, BSX, MDT, HOLX, STJ, SYK, ZMH

Posted on May 21, 2012 by Geoff Noir

Given Imaging Ltd. (NASDAQ:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, declared on Monday that novel studies verify the value of its PillCam ESO as a tool to assist triage patients with upper gastrointestinal bleeding …

Posted in Healthcare, Latest Headlines | Tagged Boston Scientific, BSX, Given Imaging, GIVN, Hologic, HOLX, MDT, Medtronic, NASDAQ:GIVN, NASDAQ:HOLX, NYSE:BSX, NYSE:MDT, NYSE:STJ, NYSE:SYK, NYSE:ZMH, St. Jude Medical, STJ, Stryker, SYK, Zimmer, ZMH | Comments Off

Stryker lowers full year guidance

Posted on January 11, 2012 by Cameron White

Stryker Corp. (NYSE:SYK) is trading fairly flat today despite reporting an 11 percent increase in fourth quarter sales.

The medical device maker posted a profit of 74 cents per share, excluding one time items the company would have posted a …

Posted in Healthcare, Main Post | Tagged analyst, company, currency exchange rates, earnings, estimates, expectations, guidance, medical device, NYSE, NYSE:SYK, profit, quarter, report, revenue, sales, share, Stryker, SYK, trading, Wall Street | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.